SouthErn China REgisTry for Stroke on Traditional Chinese Medicine (SECRETS-TCM)

Yefeng Cai

Status: Unknown

Conditions: Subarachnoid Hemorrhage; Cerebral Hemorrhage; Cerebral Infarction; Stroke; Transient Ischemic Attack

Treatments: Other: observational only-no intervention

Study type: Observational

Funder types: Other

Identifiers

NCT03380481

201604020003

Details and patient eligibility

About

Stroke is the first most common cause of death in China and one of the major causes of functional disability in the adult population.The burden of stoke is significantly increased in China in recent years.

In order to investigate the prognosis of stroke, with diagnostic and treatment information of traditional Chinese medicine (TCM), and assess the effectiveness and safety of TCM for stroke in southern China, the investigators will conduct this multicenter prospective registry study in southern China. This study will recruit 10,000 consecutive eligible patients with acute stroke from more than 50 hospitals. 24 months follow-up will be carried out on-site in hospitals and by telephone to track endpoint (including all-cause mortality, composite cerebrovascular and cardiovascular events at one and two year follow up, and neurological and functional assessments).

Enrollment: 10,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. ≥18 years.
2. Patients within 14 days of onset of acute stroke (including acute cerebral infarction, transient ischemic attack, acute cerebral hemorrhage, acute subarachnoid hemorrhage).
3. The patient and/or guardian agree to participate in this study.

Exclusion criteria

1. Patients with silent cerebrovascular disease.
2. Patients with non-cerebrovascular disease events.

Trial design

10,000 participants in 1 patient group

SECRETS-TCM

Description:

Stroke patients who treated by western medicine and/or traditional Chinese medicine in southern China

Treatment:

Other: observational only-no intervention